TRU-SENTIMENT · DeltaNeutral
TEM Trading Analysis - 10/02/2026 03:53 PM — TRU-SENTIMENT
Options chain · Stock chart · Baseline chart
TEM (Tempus AI Inc. Class A Common Stock) at $76.84. True Sentiment Bullish, delta 40-60 call 90% / put 10%, call $4,240,870 vs put $488,073. RSI 70.8.
- Symbol
- TEM
- Price
- $76.84
- Article bias (separate from True Sentiment)
- neutral
- Conviction
- medium
- Published
- 2026-10-02 15:53:00 ET
- Author
- DeltaNeutral staff
True Sentiment Analysis
Options sentiment is Bullish under the supplied Delta 40–60 methodology.
Call dollar volume: $4.24M (89.70%)
Put dollar volume: $0.49M (10.30%)
Total dollar volume: $4.73M
Call contracts: 4,383
Put contracts: 495
The options flow shows strong directional call conviction, with nearly nine times more call dollar volume than put dollar volume. This suggests that traders using the filtered methodology are positioning for near-term upside or a rebound. However, the separate spread-recommendation data explicitly identifies a divergence: options sentiment is bullish, while technicals show no clear direction. The conflict is understandable because price has recently dropped below the 5-day SMA despite remaining above the 20-day and 50-day averages.
Key Statistics: TEM
Fundamental Snapshot
Valuation
| P/E (trailing) | 39.30 |
| EPS (trailing 12 mo) | $-1.44 |
| Market cap | $13.95B |
| Shares outstanding | 181.6M |
Dividend
| Dividend yield | 0.00% |
Risk & range
| 52-week low | $40.77 |
| 52-week high | $104.32 |
| Historical volatility | 86.4% |
Ownership & trading
| Institutional ownership | 40.6% |
| Average daily volume | 7.0M sh |
Reported figures; no analyst estimates.
📈 Analysis
TEM Stock Analysis
TEM closed the latest available daily session at $76.91, while the final embedded five-minute bar closed at $76.84 on October 2, 2026. The stock remains above its 20-day and 50-day moving averages, but it has pulled back sharply from its 30-day high of $89.09. The technical picture is mixed: MACD and medium-term trend structure remain positive, while RSI is overbought and recent price action shows momentum cooling.
News Headlines & Context
Important distinction: The embedded dataset does not include verified news articles, official company announcements, earnings dates, or press-release links. The following items are general contextual themes that may be relevant to TEM, rather than confirmed headlines supplied by the dataset.
- Earnings and guidance: For a growth-oriented healthcare and technology stock such as TEM, quarterly revenue growth, margins, cash generation, and forward guidance can produce substantial volatility. No confirmed earnings date is included in the embedded data.
- AI-enabled healthcare adoption: Investment in artificial intelligence, clinical decision support, diagnostics, and healthcare data partnerships could support the long-term growth narrative. The supplied data does not quantify how much of TEM’s valuation depends on these initiatives.
- Commercial execution and partnerships: New customers, hospital or health-system relationships, data partnerships, and reimbursement developments can be important catalysts for the company’s business outlook. No specific new contract or partnership is confirmed in the supplied data.
- Valuation sensitivity: TEM’s supplied trailing P/E is 39.30, despite reported trailing EPS of -$1.44. That combination can make the stock sensitive to expectations for future profitability and can increase downside risk if execution falls short.
- Recent market reaction: The embedded X posts describe TEM as a “top loser” and discuss a possible gap at $70. These are social-media observations, not verified company news, but they are directionally consistent with the stock’s decline from $89.09 to approximately $76.91.
News context should therefore be treated as a monitoring framework. The data-driven analysis below does not assume any unverified catalyst.
X/Twitter Sentiment
The embedded live X data contains ten citation-verified posts. The discussion is mixed and heavily promotional, but it includes bearish references to TEM’s recent price weakness and a warning about a potential $70 gap.
| User | Post | Sentiment | Time | Link |
|---|---|---|---|---|
| mochitbear | October 1 2026 - Top Losers $TEM | Bearish | Thu, 01 Oct 2026 23:53:41 GMT | View post |
| Ninja250_syk | I' created a dedicated WhatsApp group for $TAP $TEM $RTX shareholders and active traders to connect, share insights, and get tI' latest updates. | Neutral | Thu, 01 Oct 2026 22:46:35 GMT | View post |
| _thehalparker | My WhatsApp stock group brings together investors from around the world. 📈 I share daily stocks with high short-term momentum potential for discussion and research. Join the private group: 👉 https://stockanalyst.cc $HIG $SEDG $DE $TEM $LFEX $WJ | Neutral | Thu, 01 Oct 2026 22:40:49 GMT | View post |
| n_n_n_NNJ | I' created a dedicated WhatsApp group for $PENN $TAP $TEM shareholders and active traders to connect, share insights, and get tI' latest updates. | Neutral | Thu, 01 Oct 2026 22:20:46 GMT | View post |
| AmazingStocks26 | $COSM Cosmos Health's Brands Reach More Than 40 Countries Across Europe, the Middle East, North America and Asia, Addressing Global Markets Estimated at Approximately $946 Billion https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/cosmos-healths-brands-reach-more-than-40-countries-across-europe-the-1230206 $SERV $PGY $NNE $BBAI $MARA $WULF $APLD $CLSK $QUBT $NVTS $TEM | Neutral | Thu, 01 Oct 2026 22:18:19 GMT | View post |
| pua_11_ | $TAP $TEM $RTX . If you hold any of the aforementioned stocks, you should definitely pay attention to him; I made $80,000 by following his tradesdes . An outstanding stock analyst 🔗@foarctwales He is an excellent stock analyst—believe me. An outstanding stock analyst | Bullish | Thu, 01 Oct 2026 22:00:50 GMT | View post |
| VinceP29847 | GAP at $70 needs to be closed or $TEM is dead money. Don't buy until GAP is closed. All gaps get closed. | Bearish | Thu, 01 Oct 2026 21:58:04 GMT | View post |
| baixonatural | $TAP $TEM $RTX . If you hold any of the aforementioned stocks, you should definitely pay attention to him; I made $80,000 by following his tradesdes . An outstanding stock analyst 🔗@foarctwales He is an excellent stock analyst—believe me. An outstanding stock analyst | Bullish | Thu, 01 Oct 2026 21:50:26 GMT | View post |
| tweetatmehomie | This tweet topped DX stonks. 😜 $GRAL $NTRA $TWST $TXG $GH $ADPT $BLLN $TEM $WGS | Neutral | Thu, 01 Oct 2026 21:30:57 GMT | View post |
| stocksgainer | $COSM Cosmos Health's Brands Reach More Than 40 Countries Across Europe, the Middle East, North America and Asia, Addressing Global Markets Estimated at Approximately $946 Billion https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/cosmos-healths-brands-reach-more-than-40-countries-across-europe-the-1230206 $IREN $VOO $INTC $FFAI $TEM $PGY | Neutral | Thu, 01 Oct 2026 21:16:44 GMT | View post |
Summary: The posts are broadly mixed, with bearish observations about TEM’s recent decline and $70 gap outweighing several neutral promotional posts and a small number of bullish analyst-promotion posts.
Fundamental Analysis
| Metric | Supplied value | Interpretation |
|---|---|---|
| Market capitalization | $13.95B | Establishes TEM as a meaningful, but still growth-sensitive, public company. |
| Trailing EPS | -$1.44 | Reported trailing earnings are negative. |
| Trailing P/E | 39.30 | The stock is valued at a relatively high earnings multiple despite negative trailing EPS, suggesting the market is pricing in future profitability. |
| Forward P/E | Not provided | Forward valuation cannot be assessed from the embedded data. |
| PEG ratio | Not provided | A growth-adjusted valuation comparison cannot be made. |
| Institutional ownership | 40.61% | Meaningful institutional participation may support liquidity, but the supplied data does not show recent institutional buying or selling. |
| Dividend yield | 0.00% | No dividend income component is evident in the supplied data. |
| Historical volatility | 86.43% | Very high volatility increases the probability of large price swings. |
Revenue growth: Revenue growth data is not provided. Year-over-year growth, recent revenue trends, and forward estimates therefore cannot be evaluated from the embedded data.
Profitability: Gross margin, operating margin, and net margin are not provided. The only profitability indicators available are trailing EPS of -$1.44 and the reported trailing P/E of 39.30. The combination means that conventional earnings-based valuation support is not yet demonstrated by positive trailing EPS.
Valuation: The supplied P/E of 39.30 may appear elevated compared with mature, low-growth companies, particularly when paired with negative trailing EPS. A sector or peer comparison cannot be completed from the embedded data because no peer multiples, forward P/E, PEG ratio, or analyst estimates are supplied.
Balance sheet and cash flow: Debt-to-equity, free cash flow, return on equity, and margins are unavailable. These omissions are important limitations because they prevent a complete assessment of financial strength, profitability quality, and cash-generation capacity.
Analyst consensus: No analyst recommendation, target price, or number of analyst opinions is provided. The data-driven conclusion is therefore neutral on analyst support rather than assuming bullish or bearish consensus.
Fundamental conclusion: TEM’s valuation is dependent on future growth and profitability, while current trailing EPS remains negative. That profile can coexist with strong technical momentum, but it increases sensitivity to execution misses, changing growth expectations, and market-wide de-risking.
Current Market Position
| Measure | Value |
|---|---|
| Latest daily close | $76.91 |
| Latest embedded five-minute close | $76.84 |
| October 1 daily open | $81.98 |
| October 1 daily high | $82.81 |
| October 1 daily low | $75.92 |
| October 1 daily volume | 6.10M |
| 20-day average volume | 5.88M |
| 30-day high | $89.09 |
| 30-day low | $57.72 |
TEM fell from $82.49 on September 30 to $76.91 on October 1, a decline of approximately 6.77%. The October 1 close was near the lower end of the day’s range, with a low of $75.92. Volume of 6.10M was slightly above the 20-day average of 5.88M, consistent with meaningful participation in the selloff.
The latest five-minute bars show a short-term pause rather than a clear rebound: the final bar moved from $76.80 to $76.84, following closes of $77.18, $76.98, and $77.13. Intraday momentum is therefore neutral-to-soft near the end of the supplied session.
Technical Analysis
Technical Indicators
Interactive charts load with JavaScript. This text is the crawlable summary.